LumaCina Appoints Gary Bird as CEO to Accelerate Growth and Expand Global Sterile Injectables Portfolio

Executive Chair Mark Crotty to continue guiding long-term strategic direction

PERTH, Australia, July 14, 2026 /PRNewswire/ -- LumaCina, a global supplier and marketer of sterile injectable pharmaceutical products and a Bridgewest Group portfolio company, announced the appointment of Gary Bird as Chief Executive Officer.

Read More: PRnewswireNews - Jornal Magazine